Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature.

导出原文传递

翻译打印收藏纠错

第一作者： Tomoo,Yamazaki

第一单位： Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. Electronic address: ymzktm6@shinshu-u.ac.jp.

作者： Tomoo,Yamazaki ^[1] ; Satoru,Joshita ^[2] ; Tetsuya,Ichijo ^[3] ; Hiroyuki,Kobayashi ^[2] ; Shun-Ichi,Wakabayashi ^[2] ; Yuki,Yamashita ^[2] ; Ayumi,Sugiura ^[2] ; Fumihiro,Kawakami ^[4] ; Hideyuki,Nakazawa ^[4] ; Takeji,Umemura ^[5]

作者单位： Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. Electronic address: ymzktm6@shinshu-u.ac.jp. ^[1] Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. ^[2] Department of Gastroenterology, Japanese Red Cross Society Azumino Hospital, 5685 Toyoshina, Azumino, Nagano 399-8205, Japan. ^[3] Department of Medicine, Division of Hematology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. ^[4] Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan; Department of Life Innovation, Institute for Biomedical Sciences, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. ^[5]

关键词 Daratumumab Exacerbation Glecaprevir/pibrentasvir Hepatitis C virus